4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-23-009710
Options or other derivatives
- President, CEO acquired 448,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| SANDS ARTHUR T President, CEO | 2023-02-14 | Grant or award · Employee Stock Option (right to buy) | +448,000 | 448,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…